Ponce School of Medicine-Moffitt Cancer Center partnership (2/2)

描述（由申请人提供）：扩大庞塞医学院-莫菲特癌症中心合作伙伴关系的目标是：1）保持全面的行政基础设施和程序，以执行项目和核心的关键评估，解决问题，保持质量，并为合作伙伴关系的持续扩展进行战略规划，并为合作伙伴关系教师的成功职业发展提供支持。 2)将PSM和MCC的基础科学家紧密合作，共同开展研究项目：这将为PSM的科学家提供经验丰富的癌症研究科学家作为合作者和导师以及先进技术的机会，以促进他们的职业生涯和他们的科学影响。反过来，MCC的科学家将受益于参与新的研究项目，重点是西班牙裔患者癌症的独特生物学。3)开发一个全面的培训管道，以产生癌症转化研究科学家的干部，包括基础和临床，以解决波多黎各和美国大陆学术健康中心的西班牙裔院士短缺的问题。这将产生科学家谁是知识与西班牙裔癌症健康差距的问题，并有动力进行研究，以解决这些差距。4)进行严格的外展研究，以了解沟通癌症相关信息的最有效方法，并将这些发现纳入社区外展计划。这将改善临床研究和生物库的参与，以及由MCC服务的佛罗里达和波多黎各西班牙裔社区的整体健康。5)扩大PSM三级转诊临床肿瘤学服务，社区肿瘤学家和肿瘤学研究员的教育机会，以及患者获得临床试验的机会，以改善波多黎各目前服务不足的人口的癌症护理。6)首次建立高质量的波多黎各肿瘤组织库 癌症患者，这将为基础研究科学家提供一个独特的和有价值的资源，使发现是具体的西班牙裔癌症患者，这将提供深入了解th发展的生物标志物驱动的个性化医疗为这一人口。

DESCRIPTION (provided by applicant): The objectives to expand the Ponce School of Medicine-Moffitt Cancer Center Partnership are to: 1) Maintain a comprehensive administrative infrastructure and procedures to perform critical evaluations of the projects and cores, solve problems, maintain quality, and strategically plan for continued expansion of the Partnership, and provide support for the development of the successful careers of the Partnership faculty. 2) Bring together in close collaboration basic scientists at PSM and MCC to conduct research projects: this will provide scientists at PSM access to experienced cancer research scientists as collaborators and mentors as well as advanced technologies, to advance their careers and the impact of their science. Reciprocally, the MCC scientists will benefit from becoming involved in new research projects focused on the unique biology of Hispanic patient cancers. 3) Develop a comprehensive training pipeline to produce a cadre of cancer translational research scientists, both basic and clinical, to address the shortage of Hispanic academicians on the faculties of academic health centers in Puerto Rico and the mainland US. This will produce scientists who are knowledgeable about the issues related to Hispanic cancer health disparities and motivated to perform research to address these disparities. 4) Conduct rigorous outreach research to learn the most effective ways of communicating cancer related information, and expand community outreach programs incorporating these discoveries. This will improve participation in clinical research and biobanking, and the overall health of the Hispanic community in Florida served by the MCC and in Puerto Rico. 5) Expand at the PSM tertiary referral clinical oncology services, educational opportunities for community oncologists and oncology fellows, and patient access to clinical trials to improve cancer care for the currently underserved population of Southwest Puerto Rico. 6) Establish for the first time a high quality tumor bank of tissues from Puerto Rican cancer patients that will provide a unique and valuable resource for the basic research scientists to make discoveries that are specific for Hispanic cancer patients that will provide insight for th development of biomarker driven personalized medicine for this population.